Form 8-K - Current report:
SEC Accession No. 0001213900-24-062025
Filing Date
2024-07-17
Accepted
2024-07-17 12:00:35
Documents
15
Period of Report
2024-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209557-8k_china.htm   iXBRL 8-K 32397
2 ENGLISH TRANSLATION OF THE STOCK TRANSFER AGREEMENT BY AND BETWEEN THE CHINA HEA ea020955701ex10-1_china.htm EX-10.1 19872
3 ENGLISH TRANSLATION OF THE STOCK TRANSFER AGREEMENT BY AND BETWEEN THE CHINA HEA ea020955701ex10-2_china.htm EX-10.2 19029
  Complete submission text file 0001213900-24-062025.txt   248127

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE chhe-20240711.xsd EX-101.SCH 3054
5 XBRL LABEL FILE chhe-20240711_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE chhe-20240711_pre.xml EX-101.PRE 22385
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0209557-8k_china_htm.xml XML 3276
Mailing Address 3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HARBIN CITY HEILONGJIANG PROVINCE F4 150028
Business Address 3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HARBIN CITY HEILONGJIANG PROVINCE F4 150028 011-86-451-51719407
China Health Industries Holdings, Inc. (Filer) CIK: 0001309057 (see all company filings)

EIN.: 860827216 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-51060 | Film No.: 241121484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)